ImmunityBio stock price crash: buy the dip or sell the rip?

ImmunityBio stock price crash: buy the dip or sell the rip? ImmunityBio stock price crash: buy the dip or sell the rip? Stock market Author Wajeeh Khan Mar 24, 2026, 19:25 PM ImmunityBio Inc (NASDAQ: IBRX) is under immense pressure on March 24 after the US Food and Drug Administration (FDA) issued a scathing warning letter over the firm's promotional tactics. Investors bailed on IBRX as regulators alleged the company and its billionaire founder, Dr. Patrick Soon- Shiong, used a TV ad and a high-profile podc ...